Does PALBOCICLIB Cause Hypokalaemia? 136 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Hypokalaemia have been filed in association with PALBOCICLIB (Ibrance). This represents 0.2% of all adverse event reports for PALBOCICLIB.
136
Reports of Hypokalaemia with PALBOCICLIB
0.2%
of all PALBOCICLIB reports
6
Deaths
60
Hospitalizations
How Dangerous Is Hypokalaemia From PALBOCICLIB?
Of the 136 reports, 6 (4.4%) resulted in death, 60 (44.1%) required hospitalization, and 8 (5.9%) were considered life-threatening.
Is Hypokalaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 136 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Hypokalaemia?
FUROSEMIDE (2,503)
HYDROCHLOROTHIAZIDE (1,152)
CARBOPLATIN (1,118)
PREDNISONE (967)
DEXAMETHASONE (876)
CYCLOPHOSPHAMIDE (864)
OMEPRAZOLE (851)
RITUXIMAB (822)
AMLODIPINE (815)
PANTOPRAZOLE (811)
Which PALBOCICLIB Alternatives Have Lower Hypokalaemia Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID